​

Teladoc Health (TDOC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TDOC Stock Forecast

Teladoc Health (TDOC) stock forecast, based on 40 Wall Street analysts, predicts a 12-month average price target of $8.83, with a high of $10.00 and a low of $8.00. This represents a 26.14% increase from the last price of $7.00.

$5 $9 $13 $17 $21 $25 High: $10 Avg: $8.83 Low: $8 Last Closed Price: $7

TDOC Stock Rating

Teladoc Health stock's rating consensus is Hold, based on 40 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (35.00%), 26 Hold (65.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 40 0 26 14 Strong Sell Sell Hold Buy Strong Buy

TDOC Price Target Upside V Benchmarks

TypeNameUpside
StockTeladoc Health26.14%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 31.31%

Price Target Trends

1M3M12M
# Anlaysts123
Avg Price Target$8.50$8.25$8.83
Last Closing Price$7.00$7.00$7.00
Upside/Downside21.43%17.86%26.14%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 261422--27
Dec, 251421--26
Nov, 251420--25
Oct, 251420--25
Sep, 251420--25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2025Barclays$8.50$7.5612.43%21.43%
Oct 30, 2025David GrossmanStifel Nicolaus$8.00$8.82-9.30%14.29%
Jul 30, 2025Raymond James$10.00$7.4035.14%42.86%
Dec 04, 2024Jessica TassanPiper Sandler$13.00$11.0118.07%85.71%
Oct 31, 2024Daniel GrosslightCitigroup$11.00$8.8624.15%57.14%
Oct 30, 2024Elizabeth AndersonEvercore ISI$9.00$8.861.58%28.57%
Aug 06, 2024Jessica TassanPiper Sandler$10.00$7.6031.58%42.86%
Jun 11, 2024Steve ValiquetteBarclays$20.00$10.4990.66%185.71%
May 31, 2024Glen SantangeloJefferies$10.00$11.29-11.43%42.86%
May 20, 2024Glen SantangeloJefferies$14.00$12.3912.99%100.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2025BarclaysOverweightNeutralinitialise
Oct 21, 2025CitigroupNeutralNeutralhold
Jul 30, 2025Cantor FitzgeraldOverweightOverweighthold
Dec 04, 2024Piper SandlerOverweightOverweighthold
Oct 31, 2024Cowen & Co.HoldHoldhold
Oct 31, 2024BarclaysOverweightOverweighthold
Oct 31, 2024CitigroupNeutralNeutralhold
Oct 09, 2024RBC CapitalOutperformOutperformhold
Oct 08, 2024RBC CapitalBuyBuyhold
Oct 08, 2024Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$-85 $-67 $-49 $-31 $-13 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.73$-84.60$-1.36$-5.87----
Avg Forecast$-3.25$-61.26$-1.38$-5.82$-0.89$-0.80$-0.63$-0.03
High Forecast$-3.04$-58.91$-0.99$-5.64$-0.50$-0.08$0.47$-0.02
Low Forecast$-3.42$-63.04$-1.45$-5.94$-1.23$-1.20$-1.11$-0.03
Surprise %-16.00%38.10%-1.45%0.86%----

Revenue Forecast

$2B $2B $2B $2B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.03B$2.41B$2.60B$2.57B----
Avg Forecast$2.03B$2.40B$2.61B$2.57B$2.55B$2.59B$2.66B$2.75B
High Forecast$2.11B$2.46B$2.62B$2.60B$2.61B$2.59B$2.66B$2.82B
Low Forecast$1.92B$2.33B$2.51B$2.55B$2.41B$2.58B$2.66B$2.64B
Surprise %0.35%0.18%-0.39%0.04%----

Net Income Forecast

$-550B $-430B $-310B $-190B $-70B $50B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-428.79M$-13.66B$-220.37M$-1.00B----
Avg Forecast$-385.89M$-434.22B$-220.37M$-953.23M$-156.71M$-148.59M$-92.16M$-4.11M
High Forecast$-308.71M$-347.37B$-176.29M$-928.45M$-81.96M$-12.97M$77.75M$-3.90M
Low Forecast$-463.07M$-521.06B$-264.44M$-978.01M$-201.87M$-197.67M$-182.81M$-4.24M
Surprise %11.12%-96.85%-5.04%----

TDOC Forecast FAQ

Is Teladoc Health stock a buy?

Teladoc Health stock has a consensus rating of Hold, based on 40 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 26 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Teladoc Health is a neutral investment for most analysts.

What is Teladoc Health's price target?

Teladoc Health's price target, set by 40 Wall Street analysts, averages $8.83 over the next 12 months. The price target range spans from $8 at the low end to $10 at the high end, suggesting a potential 26.14% change from the previous closing price of $7.

How does Teladoc Health stock forecast compare to its benchmarks?

Teladoc Health's stock forecast shows a 26.14% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (31.31%).

What is the breakdown of analyst ratings for Teladoc Health over the past three months?

  • January 2026: 3.70% Strong Buy, 14.81% Buy, 81.48% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 3.85% Strong Buy, 15.38% Buy, 80.77% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 4.00% Strong Buy, 16.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.

What is Teladoc Health’s EPS forecast?

Teladoc Health's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.89, marking a -84.84% decrease from the reported $-5.87 in 2024. Estimates for the following years are $-0.8 in 2026, $-0.63 in 2027, and $-0.03 in 2028.

What is Teladoc Health’s revenue forecast?

Teladoc Health's average annual revenue forecast for its fiscal year ending in December 2025 is $2.55B, reflecting a -0.94% decrease from the reported $2.57B in 2024. The forecast for 2026 is $2.59B, followed by $2.66B for 2027, and $2.75B for 2028.

What is Teladoc Health’s net income forecast?

Teladoc Health's net income forecast for the fiscal year ending in December 2025 stands at $-157M, representing a -84.35% decrease from the reported $-1.001B in 2024. Projections indicate $-149M in 2026, $-92.161M in 2027, and $-4.114M in 2028.